Clinical Development Disease Drug Trials FDA Approval 
Drug Discovery World
MAY 3, 2023
Official comments “Measuring endothelial dysfunction with the EndoPAT technology in drug trials is a cost-effective and robust method for early documentation of proof-of-concept in pulmonary, renal and vascular diseases” says Elin Rosendahl, VP Clinical Operations, Vicore Pharma.
Drug Discovery World
MARCH 7, 2023
Here at FAB our proprietary approach aims to overcome this fundamental challenge to human health as we work to discover and develop new drugs for age-associated diseases.” She founded Neuroute in 2019, with the aim of empowering patients from diverse backgrounds to participate in drug trials.
Drug Discovery World
JANUARY 17, 2024
With oncology accounting for a third of pharma’s product pipeline, significant challenges include fierce competition, high research and development costs over, 10-15 years for clinical development, and pressures to rapidly meet the demand for new treatments 2-4.
Expert insights. Personalized for you.
130 
Let's personalize your content